HMI

HMI is a New York-based research organization focused on microbiology and its potential connections to human health and disease. Its work spans applied microbiology, disease-specific research, and longevity and aging, with programs addressing the human microbiome, bacteriophages, antimicrobial resistance, novel bacterial species, and microbiota regulation. HMI also investigates conditions including Parkinson’s and Alzheimer’s diseases, amyotrophic lateral sclerosis, autism, multiple sclerosis, cancer, type 1 diabetes, and age-related infectious diseases.

The organization shares its research through scientific publications, educational resources, a research database, and news and events for the scientific community. Its published work covers topics such as bacterial DNA and neurodegenerative disease, novel cell receptor systems, antibiotic selection, and potential approaches to cancer treatment. HMI’s research and programs also include Jewish research and the study of genetic predisposition in Jewish populations.

For scientists and partners, HMI provides information on its theories, research areas, publications, and collaboration opportunities. The organization accepts donations to support its applied microbiology, disease research, and longevity programs, and offers giving options and naming opportunities.